Impaired extinction of cued fear memory and abnormal dendritic morphology in the prelimbic and infralimbic cortices in VPAC2 receptor (VIPR2)-deficient mice
Abstract:The structurally related neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) have been implicated in stress regulation and learning and memory. Several bodies of research have shown the impact of the PACAP specific receptor PAC1 on fear memory, but the roles of other PACAP receptors in regulating fear stress responses remain to be elucidated. Here we aimed to investigate the effects of genetic deletion of VIPR2 encoding the VPAC2 receptor, which bind… Show more
“…Overall, the results suggest that the activation of the VPAC2 receptor delays or limits the maturation in mouse cortical neurons. In a previous study, we also found that adult VPAC2 receptor knockout mice show abnormal dendritic morphology in the prelimbic and infralimbic cortices, but not basolateral amygdala (Ago et al, 2017). Loss of the VPAC2 receptor reorganized apical and basal dendritic arbors of prelimbic cortex neurons and apical, but not basal, dendritic arbors of infralimbic cortex neurons.…”
Section: Discussionmentioning
confidence: 52%
“…Recently, Tian et al (2019) have developed a conditional human VIPR2 CNV bacterial artificial chromosome (BAC) transgenic (hVIPR2-BAC tg) mouse model of VIPR2 CNV, and they reported that hVIPR2-BAC tg mice showed cognitive, sensorimotor gating, and social behavioral deficits and decrease in the complexity of dendritic arborization of the striatal spiny projection neurons. Additionally, VPAC2 receptor knockout mice have abnormal dendritic morphology of the prefrontal cortex neurons, but not basolateral amygdala neurons (Ago et al, 2017). These findings suggest that the VPAC2 receptor plays an important role in the regulation of the dendritic morphology and overactivation of the VPAC2 receptor might impair neural development in the brain.…”
Section: Introductionmentioning
confidence: 88%
“…The generation of VPAC2 receptor deficient mice using gene targeting has been previously reported (Harmar et al, 2002). VPAC2 receptor homozygous knockout mice and littermate wild-type mice (C57BL/6 strain) used here were obtained by crossing with VPAC2 receptor heterozygous mice (Ago et al, 2017). Mice were housed in clear cages in groups of 3-5 animals under controlled environmental conditions (22 ± 1 • C; 50 ± 10% relative humidity; a 12-h light-dark cycle, lights on at 0800 h; food and water ad libitum).…”
Takeuchi et al. VPAC2 Activation Inhibits Neurite Outgrowth induced facilitation of dendritic outgrowth was blocked by U0126. These results suggest that activation of the VPAC2 receptor impairs neurite outgrowth and decreases branching of cortical neurons by a PKA-dependent mechanism. These findings also imply that the VIPR2-linkage to mental health disorders may be due in part to deficits in neuronal maturation induced by VPAC2 receptor overactivation.
“…Overall, the results suggest that the activation of the VPAC2 receptor delays or limits the maturation in mouse cortical neurons. In a previous study, we also found that adult VPAC2 receptor knockout mice show abnormal dendritic morphology in the prelimbic and infralimbic cortices, but not basolateral amygdala (Ago et al, 2017). Loss of the VPAC2 receptor reorganized apical and basal dendritic arbors of prelimbic cortex neurons and apical, but not basal, dendritic arbors of infralimbic cortex neurons.…”
Section: Discussionmentioning
confidence: 52%
“…Recently, Tian et al (2019) have developed a conditional human VIPR2 CNV bacterial artificial chromosome (BAC) transgenic (hVIPR2-BAC tg) mouse model of VIPR2 CNV, and they reported that hVIPR2-BAC tg mice showed cognitive, sensorimotor gating, and social behavioral deficits and decrease in the complexity of dendritic arborization of the striatal spiny projection neurons. Additionally, VPAC2 receptor knockout mice have abnormal dendritic morphology of the prefrontal cortex neurons, but not basolateral amygdala neurons (Ago et al, 2017). These findings suggest that the VPAC2 receptor plays an important role in the regulation of the dendritic morphology and overactivation of the VPAC2 receptor might impair neural development in the brain.…”
Section: Introductionmentioning
confidence: 88%
“…The generation of VPAC2 receptor deficient mice using gene targeting has been previously reported (Harmar et al, 2002). VPAC2 receptor homozygous knockout mice and littermate wild-type mice (C57BL/6 strain) used here were obtained by crossing with VPAC2 receptor heterozygous mice (Ago et al, 2017). Mice were housed in clear cages in groups of 3-5 animals under controlled environmental conditions (22 ± 1 • C; 50 ± 10% relative humidity; a 12-h light-dark cycle, lights on at 0800 h; food and water ad libitum).…”
Takeuchi et al. VPAC2 Activation Inhibits Neurite Outgrowth induced facilitation of dendritic outgrowth was blocked by U0126. These results suggest that activation of the VPAC2 receptor impairs neurite outgrowth and decreases branching of cortical neurons by a PKA-dependent mechanism. These findings also imply that the VIPR2-linkage to mental health disorders may be due in part to deficits in neuronal maturation induced by VPAC2 receptor overactivation.
“…VIP play diverse roles in the central nervous system, including the control of circadian rhythms, learning and memory, psychiatric illness, and responses to stress [30]. Vipr2 ( Vpac2 ) knockout mouse lacks circadian control [30] and also exhibits impaired extinction of cued fear memory and regulation of the dendritic morphology [31]. VIPR2 is located in the subtelomeric region of chromosome 7 and VIPR2 duplications were indicated in the etiology of autism [32].…”
There is a reciprocal relationship between the circadian and the reward systems. Polymorphisms in several circadian rhythm-related (clock) genes were associated with drug addiction. This study aims to search for associations between 895 variants in 39 circadian rhythm-related genes and opioid addiction (OUD). Genotyping was performed with the Smokescreen® array. Ancestry was verified by principal/MDS component analysis and the sample was limited to European Americans (EA) (OUD; n = 435, controls; n = 138). Nominally significant associations (p < 0.01) were detected for several variants in genes encoding vasoactive intestinal peptide receptor 2 (VIPR2), period circadian regulator 2 (PER2), casein kinase 1 epsilon (CSNK1E), and activator of transcription and developmental regulator (AUTS2), but no signal survived correction for multiple testing. There was intriguing association signal for the untranslated region (3’ UTR) variant rs885863 in VIPR2, (p = .0065; OR = 0.51; 95% CI 0.31–0.51). The result was corroborated in an independent EA OUD sample (n = 398, p = 0.0036; for the combined samples). Notably, this SNP is an expression quantitative trait locus (cis-eQTL) for VIPR2 and a long intergenic non-coding RNA, lincRNA 689, in a tissue-specific manner, based on the Genotype-Tissue Expression (GTEx) project. Vasoactive intestinal peptide (VIP) is an important peptide of light-activated suprachiasmatic nucleus cells. It regulates diverse physiological processes including circadian rhythms, learning and memory, and stress response. This is the first report of an association of a VIPR2 variant and OUD. Additionally, analysis of combinations of single nucleotide polymorphisms (SNPs) genotypes revealed an association of PER2 SNP rs80136044, and SNP rs4128839, located 41.6 kb downstream of neuropeptide Y receptor type 1 gene, NPY1R (p = 3.4 × 10−6, OR = 11.4, 95% CI 2.7–48.2). The study provides preliminary insight into the relationship between genetic variants in circadian rhythm genes and long non-coding RNA (lncRNAs) in their vicinity, and opioid addiction.
“…Pituitary adenylate cyclase-activating polypeptide can also influence memory via modulation of intrinsic physiology (see Open Questions) and via developmental maturation of memory circuits (reviewed in Shen et al, 2013 ). For example, developmental knockout of VPAC2 which is sensitive to both VIP and PACAP prevented the formation of fear extinction memory in adulthood ( Ago et al, 2017 ). Importantly, VPAC2-KO mice had reduced cell size and dendritic branching in the prelimbic cortex, morphological changes similar to those observed after chronic corticosterone exposure and chronic stress, conditions which also produce fear extinction deficits ( Wellman, 2001 ; Radley et al, 2004 , 2006 ; Moench and Wellman, 2017 ; reviewed in Wellman et al, 2020 ).…”
Section: Cellular and Synaptic Physiologymentioning
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a highly conserved neuropeptide that regulates neuronal physiology and transcription through Gs/Gq-coupled receptors. Its actions within hypothalamic, limbic, and mnemonic systems underlie its roles in stress regulation, affective processing, neuroprotection, and cognition. Recently, elevated PACAP levels and genetic disruption of PAC1 receptor signaling in humans has been linked to maladaptive threat learning and pathological stress and fear in post-traumatic stress disorder (PTSD). PACAP is positioned to integrate stress and memory in PTSD for which memory of the traumatic experience is central to the disorder. However, PACAP’s role in memory has received comparatively less attention than its role in stress. In this review, we consider the evidence for PACAP-PAC1 receptor signaling in learning and plasticity, discuss emerging data on sex differences in PACAP signaling, and raise key questions for further study toward elucidating the contribution of PACAP to adaptive and maladaptive fear learning.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.